135 related articles for article (PubMed ID: 38053271)
41. ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature Review.
Gareton A; Pierron G; Mokhtari K; Tran S; Tauziède-Espariat A; Pallud J; Louvel G; Meary E; Capelle L; Chrétien F; Varlet P
J Neuropathol Exp Neurol; 2018 Jul; 77(7):537-541. PubMed ID: 29788195
[TBL] [Abstract][Full Text] [Related]
42. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
[TBL] [Abstract][Full Text] [Related]
43. Durable response to crizotinib in metastatic angiomatoid fibrous histiocytoma with EWSR1-CREB1 fusion and ALK overexpression.
Ngo C; Grinda T; Boilève A; Levy A; Le Pechoux C; Haddag L; Valent A; Lazure T; Briand S; Honoré C; Faron M; Mir O; Bahleda R; Verret B; Le Cesne A
Ann Oncol; 2022 Aug; 33(8):848-850. PubMed ID: 35568279
[No Abstract] [Full Text] [Related]
44. Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.
Dunham C; Hussong J; Seiff M; Pfeifer J; Perry A
Am J Surg Pathol; 2008 Mar; 32(3):478-84. PubMed ID: 18300800
[TBL] [Abstract][Full Text] [Related]
45. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
[TBL] [Abstract][Full Text] [Related]
46. Myoepithelial and oral intracranial myxoid mesenchymal tumor-like neoplasms as diagnostic considerations of the ever-expanding extracranial myxocollagenous tumors harboring FET-CREB fusions.
Lee PH; Kao YC; Hsieh TH; Liao JB; Li CF; Lee JC; Chang YM; Chang CD; Huang SC; Chen TJ; Liu TT; Yu SC; Huang HY
Pathol Res Pract; 2022 Jan; 229():153700. PubMed ID: 34929603
[TBL] [Abstract][Full Text] [Related]
47. Angiomatoid fibrous histiocytoma: Report of two cases, initially construed as sarcoma with unusual clinico-pathological features.
Pasricha S; Durga G; Sharma A; Pruthi M; Kamboj M; Gupta G; Jajodia A; Mahawar V; Babu Koyyala VP; Mehta A
Indian J Pathol Microbiol; 2022; 65(4):921-924. PubMed ID: 36308208
[TBL] [Abstract][Full Text] [Related]
48. A Comparison of Morphologic and Molecular Features of BRAF, ALK, and NTRK1 Fusion Spitzoid Neoplasms.
Amin SM; Haugh AM; Lee CY; Zhang B; Bubley JA; Merkel EA; Verzì AE; Gerami P
Am J Surg Pathol; 2017 Apr; 41(4):491-498. PubMed ID: 27776007
[TBL] [Abstract][Full Text] [Related]
49. Fusion genes in angiomatoid fibrous histiocytoma.
Hallor KH; Micci F; Meis-Kindblom JM; Kindblom LG; Bacchini P; Mandahl N; Mertens F; Panagopoulos I
Cancer Lett; 2007 Jun; 251(1):158-63. PubMed ID: 17188428
[TBL] [Abstract][Full Text] [Related]
50. Clinicopathological features of angiomatoid fibrous histiocytoma: a series of 21 cases with variant morphology.
Shi H; Li H; Zhen T; Zhang F; Dong Y; Zhang W; Han A
Int J Clin Exp Pathol; 2015; 8(1):772-8. PubMed ID: 25755773
[TBL] [Abstract][Full Text] [Related]
51. Intracranial myxoid mesenchymal tumor with EWSR1-CREB1 gene fusion: a case report and literature review.
Komatsu M; Yoshida A; Tanaka K; Matsuo K; Sasayama T; Kojita Y; Kanda T; Kodama Y; Itoh T; Hirose T
Brain Tumor Pathol; 2020 Apr; 37(2):76-80. PubMed ID: 32215804
[TBL] [Abstract][Full Text] [Related]
52. A systematic comparison of pan-Trk immunohistochemistry assays among multiple cancer types.
Haberecker M; Töpfer A; Melega F; Moch H; Pauli C
Histopathology; 2023 Jun; 82(7):1003-1012. PubMed ID: 36759438
[TBL] [Abstract][Full Text] [Related]
53. Angiomatoid fibrous histiocytoma with t(2;22)(q33;q12.2) and EWSR1 gene rearrangement.
Shao L; Singh V; Cooley L
Pediatr Dev Pathol; 2009; 12(2):143-6. PubMed ID: 18666823
[TBL] [Abstract][Full Text] [Related]
54. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
[TBL] [Abstract][Full Text] [Related]
55. Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.
Shibayama T; Shimoi T; Mori T; Noguchi E; Honma Y; Hijioka S; Yoshida M; Ogawa C; Yonemori K; Yatabe Y; Yoshida A
Am J Surg Pathol; 2022 Jan; 46(1):134-146. PubMed ID: 34049318
[TBL] [Abstract][Full Text] [Related]
56. Atypical fibrous histiocytoma of the skin with CD30 and p80/ALK1 positivity and ALK gene rearrangement.
Szablewski V; Laurent-Roussel S; Rethers L; Rommel A; Van Eeckhout P; Camboni A; Willocz P; Copie-Bergman C; Ortonne N
J Cutan Pathol; 2014 Sep; 41(9):715-9. PubMed ID: 24666231
[TBL] [Abstract][Full Text] [Related]
57. Intracranial myxoid mesenchymal tumor with EWSR1-CREB1 fusion.
Libbrecht S; Van Der Meulen J; Mondelaers V; Baert E; Vande Walle C; Van Dorpe J; Creytens D
Pathol Res Pract; 2020 Dec; 216(12):153239. PubMed ID: 33080563
[TBL] [Abstract][Full Text] [Related]
58. Paraneoplastic Syndrome of Angiomatoid Fibrous Histiocytoma May Be Caused by EWSR1-CREB1 Fusion-induced Excessive Interleukin-6 Production.
Akiyama M; Yamaoka M; Mikami-Terao Y; Yokoi K; Inoue T; Hiramatsu T; Ashizuka S; Yoshizawa J; Katagi H; Ikegami M; Ida H; Nakazawa A; Okita H; Matsumoto K
J Pediatr Hematol Oncol; 2015 Oct; 37(7):554-9. PubMed ID: 26165403
[TBL] [Abstract][Full Text] [Related]
59.
Overbeck TR; Reiffert A; Schmitz K; Rittmeyer A; Körber W; Hugo S; Schnalke J; Lukat L; Hugo T; Hinterthaner M; Reuter-Jessen K; Schildhaus HU
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296928
[TBL] [Abstract][Full Text] [Related]
60. Evidence of Chemoresponsiveness in Unresectable Metastatic Angiomatoid Fibrous Histiocytoma.
Corley EA; Pace E; Barnacle AM; Patel PA; Thway K; Chisholm JC
J Pediatr Hematol Oncol; 2023 Mar; 45(2):e279-e284. PubMed ID: 36716049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
